Jefferies Financial Group Inc. Buys 28,204 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Jefferies Financial Group Inc. increased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 138.9% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 48,514 shares of the medical device company's stock after purchasing an additional 28,204 shares during the period. Jefferies Financial Group Inc.'s holdings in Cooper Companies were worth $4,460,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Byrne Asset Management LLC acquired a new stake in Cooper Companies during the fourth quarter worth approximately $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the fourth quarter valued at approximately $34,000. New Age Alpha Advisors LLC acquired a new stake in Cooper Companies during the fourth quarter worth approximately $38,000. Covestor Ltd increased its stake in Cooper Companies by 35.5% during the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares during the period. Finally, West Financial Advisors LLC acquired a new position in Cooper Companies in the 4th quarter valued at $49,000. Institutional investors own 24.39% of the company's stock.

Cooper Companies Price Performance

Shares of NASDAQ COO traded up $1.47 during midday trading on Friday, reaching $82.92. 1,519,674 shares of the company were exchanged, compared to its average volume of 1,465,112. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The stock has a market cap of $16.58 billion, a P/E ratio of 42.52, a PEG ratio of 2.25 and a beta of 1.08. The stock's 50-day moving average price is $80.16 and its 200-day moving average price is $90.35.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, meeting analysts' consensus estimates of $0.92. The business had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the topic of several analyst reports. BNP Paribas raised Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Needham & Company LLC reissued a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. JPMorgan Chase & Co. cut their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Robert W. Baird lowered their price objective on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Finally, Citigroup lowered their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a research report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.